Instil Bio, Inc.
TIL
$11.49
$0.716.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 40.98% | -43.42% | -16.04% | 7.97% | 65.86% |
| Total Depreciation and Amortization | -98.67% | -98.77% | -49.85% | -28.47% | -5.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -79.88% | 167.38% | 180.23% | 1,158.73% | -77.74% |
| Change in Net Operating Assets | 107.94% | -393.45% | 98.85% | -287.63% | -858.37% |
| Cash from Operations | 47.56% | -39.38% | 70.85% | 21.09% | -39.56% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00% | -97.60% | -- | -79.45% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.38% | -103.63% | -0.40% | 1.84% | 164.93% |
| Cash from Investing | -57.37% | -103.36% | 3.98% | -6.81% | 754.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 137.74% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 137.74% | -- | -- | -- | 127.09% |
| Foreign Exchange rate Adjustments | -159.52% | 362.50% | 168.25% | -242.11% | 149.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,388.98% | -754.43% | 209.19% | 622.18% | 99.08% |